BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 18284804)

  • 1. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.
    Draelos ZD
    Curr Med Res Opin; 2008 Apr; 24(4):985-94. PubMed ID: 18284804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.
    Siegfried EC; Jaworski JC; Kaiser JD; Hebert AA
    BMC Pediatr; 2016 Jun; 16():75. PubMed ID: 27267134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption.
    Pariser D
    Am J Ther; 2009; 16(3):264-73. PubMed ID: 19262357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis.
    El-Batawy MM; Bosseila MA; Mashaly HM; Hafez VS
    J Dermatol Sci; 2009 May; 54(2):76-87. PubMed ID: 19303745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema?
    Wilkes SR; Nankervis H; Tavernier E; Maruani A; Williams HC
    J Invest Dermatol; 2016 Oct; 136(10):1944-1949. PubMed ID: 27265005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
    Kalavala M; Dohil MA
    Am J Clin Dermatol; 2011 Feb; 12(1):15-24. PubMed ID: 21067248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
    Frankel HC; Qureshi AA
    Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety considerations in topical treatments for atopic dermatitis.
    Nicol NH
    Pediatr Nurs; 2011; 37(6):295-301; quiz 302. PubMed ID: 22256690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atopic dermatitis].
    Gerner T; Skov L; Thyssen JP
    Ugeskr Laeger; 2018 Jan; 180(4):. PubMed ID: 29393034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus ointment (Protopic) for atopic dermatitis.
    Pascual JC; Fleisher AB
    Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing treatment challenges in atopic dermatitis with novel topical therapies.
    Silverberg JI; Nelson DB; Yosipovitch G
    J Dermatolog Treat; 2016 Nov; 27(6):568-576. PubMed ID: 27165566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis.
    Wollina U
    Am J Clin Dermatol; 2007; 8(3):157-73. PubMed ID: 17492844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials.
    Schmitt J; von Kobyletzki L; Svensson A; Apfelbacher C
    Br J Dermatol; 2011 Feb; 164(2):415-28. PubMed ID: 20819086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Position statement: topical calcineurin inhibitors in atopic dermatitis.
    Remitz A; De Pità O; Mota A; Serra-Baldrich E; Vakirlis E; Kapp A
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2074-2082. PubMed ID: 30288799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of Atopic Dermatitis and Topical Therapies.
    Mayba JN; Gooderham MJ
    J Cutan Med Surg; 2017; 21(3):227-236. PubMed ID: 28300440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.
    Frankel A; Sohn A; Patel RV; Lebwohl M
    J Drugs Dermatol; 2011 Jun; 10(6):666-72. PubMed ID: 21637908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.